SCHEMBL6074004

SCHEMBL6074004

COC(=O)C(=O)c1cc2c(cc1OC)CCC(=O)N2C

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 6/20 0.47
CYP11B2 P19099 6/20 0.47
CYP19A1 P11511 5/20 0.47
CYP3A4 P08684 3/20 0.47
TRIM24 O15164 2/20 0.47
CYP1A2 P05177 2/20 0.39
GAA P10253 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
MAPK1 P28482 1/20 0.34
CYP17A1 P05093 1/20 0.34
DHODH Q02127 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
KDM4E B2RXH2 1/20 0.34
HSD17B10 Q99714 1/20 0.34
SYK P43405 1/20 0.34
TYRO3 Q06418 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6074636 0.88 CYP11B1 (0.48) CYP11B1CYP11B2CYP19A1CYP3A4TRIM24
SCHEMBL6074045 0.87 CYP11B1 (0.46) CYP11B1CYP11B2CYP19A1CYP3A4TRIM24
SCHEMBL4157549 0.85 CYP11B1 (0.50) CYP11B1CYP11B2CYP19A1CYP3A4TRIM24
SCHEMBL12057333 0.77 CYP11B1 (0.52) CYP11B1CYP11B2CYP19A1CYP3A4TRIM24
SCHEMBL6074490 0.75 CYP11B1 (0.50) CYP11B1CYP11B2CYP19A1CYP3A4TRIM24
SCHEMBL6073535 0.74 CYP11B1 (0.46) CYP11B1CYP11B2CYP19A1CYP3A4TRIM24
SCHEMBL23011989 0.73 MAP3K5 (0.45) CYP11B1CYP11B2CYP19A1CYP3A4TRIM24
SCHEMBL4156212 0.72 CYP11B1 (0.48) CYP11B1CYP11B2CYP19A1CYP3A4TRIM24
SCHEMBL16431883 0.72 CYP11B1 (0.56) CYP11B1CYP11B2CYP19A1CYP3A4TRIM24
SCHEMBL6073506 0.71 CYP11B1 (0.47) CYP11B1CYP11B2CYP19A1CYP3A4TRIM24

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7119207-B2 Benzoamide piperidine containing compounds and related compounds PFIZER INC (US) 2006-10-10 US disclosed
US-20030087925-A1 Benzoamide piperidine containing compounds and related compounds PFIZER INC. 2003-05-08 US disclosed
EP-1272484-A2 BENZOAMIDE PIPERIDINE COMPOUNDS AS SUBSTANCE P ANTAGONISTS Pfizer Products Inc. (US) 2003-01-08 EP disclosed
WO-2001077100-A2 BENZOAMIDE PIPERIDINE COMPOUNDS AS SUBSTANCE P ANTAGONISTS PFIZER PRODUCTS INC. (US) 2001-10-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030087925-A1 Benzoamide piperidine containing compounds and related compounds TACR1, VIPR1, VIPR2 CYP11B1 2904/4885CYP11B2 3109/4885CYP19A1 918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.